Clinical Trial Update: To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing the safety and imaging patterns of cyclotron-produced technetium versus generator-produced technetium in patients with thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Technetium-99m (technetium-99m)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Thyroid Neoplasms | Phase 1 | Status: COMPLETED